Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre J Issa

Showing results (31-40 of 203) with videos related to

Pageof 21
Sort By:
Critical Reviews in Oncology/Hematology|October 7, 2006
Decitabine--bedside to benchYasuhiro Oki, Etsuko Aoki, Jean-Pierre J Issa
Epigenomes|June 25, 2025
DNA Methylation, Aging, and CancerHimani Vaidya, Jaroslav Jelinek, Jean-Pierre J Issa
Molecular and Cellular Biology|December 17, 2002
Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancerYutaka Kondo, LanLan Shen, Jean-Pierre J Issa
Nature Reviews. Genetics|September 16, 2016
Targeting the cancer epigenome for therapyPeter A Jones, Jean-Pierre J Issa, Stephen Baylin
Nature Reviews. Drug Discovery|May 3, 2005
AzacitidineJean-Pierre J Issa, Hagop M Kantarjian, Peter Kirkpatrick
Cancer Letters|April 7, 2009
Histone deacetylase inhibitors as anti-neoplastic agentsNicolas Batty, Gabriel G Malouf, Jean Pierre J Issa
Epigenomics|November 7, 2015
Will next-generation agents deliver on the promise of epigenetic hypomethylation therapy?James N Lowder, Pietro Taverna, Jean-Pierre J Issa
Cancer Biology & Therapy|October 7, 2004
Regulation of RARbeta1 expression in head and neck cancer cells by cell density-dependent chromatin remodelingEmile M Youssef, Jean-Pierre J Issa, Reuben Lotan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Combining epigenetic and cytotoxic therapy in the treatment of solid tumorsElizabeth R Plimack, David J Stewart, Jean-Pierre J Issa
Cancer Journal (Sudbury, Mass.)|September 20, 2017
Epigenetics and Precision OncologyRachael J Werner, Andrew D Kelly, Jean-Pierre J Issa
Pageof 21

Showing results (31-40 of 203) with videos related to

Sort By:
Pageof 21
Critical Reviews in Oncology/Hematology|October 7, 2006
Decitabine--bedside to benchYasuhiro Oki, Etsuko Aoki, Jean-Pierre J Issa
Epigenomes|June 25, 2025
DNA Methylation, Aging, and CancerHimani Vaidya, Jaroslav Jelinek, Jean-Pierre J Issa
Molecular and Cellular Biology|December 17, 2002
Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancerYutaka Kondo, LanLan Shen, Jean-Pierre J Issa
Nature Reviews. Genetics|September 16, 2016
Targeting the cancer epigenome for therapyPeter A Jones, Jean-Pierre J Issa, Stephen Baylin
Nature Reviews. Drug Discovery|May 3, 2005
AzacitidineJean-Pierre J Issa, Hagop M Kantarjian, Peter Kirkpatrick
Cancer Letters|April 7, 2009
Histone deacetylase inhibitors as anti-neoplastic agentsNicolas Batty, Gabriel G Malouf, Jean Pierre J Issa
Epigenomics|November 7, 2015
Will next-generation agents deliver on the promise of epigenetic hypomethylation therapy?James N Lowder, Pietro Taverna, Jean-Pierre J Issa
Cancer Biology & Therapy|October 7, 2004
Regulation of RARbeta1 expression in head and neck cancer cells by cell density-dependent chromatin remodelingEmile M Youssef, Jean-Pierre J Issa, Reuben Lotan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Combining epigenetic and cytotoxic therapy in the treatment of solid tumorsElizabeth R Plimack, David J Stewart, Jean-Pierre J Issa
Cancer Journal (Sudbury, Mass.)|September 20, 2017
Epigenetics and Precision OncologyRachael J Werner, Andrew D Kelly, Jean-Pierre J Issa
Pageof 21